Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine
Mahdi Abdoli Shadbad, Nima Hemmat, Vahid Khaze, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 13

Showing 13 citing articles:

CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Grace Guzman, Megan R. Reed, Kevin Bielamowicz, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 5, pp. 479-489
Open Access | Times Cited: 77
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 18
Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
Amin Daei Sorkhabi, Aila Sarkesh, Hossein Saeedi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Immunotherapy Influence On Human Body: Glycan Engineering Antibody-Based Cancer Treatments
Kafayat Motomori Bakare, Anyanwu Nkeiruka, Ugochukwu Okwudili Matthew, et al.
Journal of Community Medicine and Public Health Reports (2024)
Open Access | Times Cited: 2
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cells in lung cancer brain metastasis.
Jens Blobner, Laura Dengler, Constantin Eberle, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
Combating challenges in CAR-T cells with engineering immunology
Clement Yisai Wang, Stephanie Po Ting Cheung, Ryohichi Sugimura
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4
Tumor-infiltrating CD8+ sub-populations in primary and recurrent glioblastoma: An in-silico study
Mahdi Abdoli Shadbad, Adib Miraki Feriz, Behzad Baradaran, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27329-e27329
Open Access
EDIÇÃO GENÉTICA NO REPARO DE GENES TUMORAIS EM TECIDOS MOLES: UMA REVISÃO BIBLIOGRÁFICA
Farley Silva Duarte, Marttina Rossi Milão, Beatriz de Sousa Faria, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 8, pp. 4286-4298
Open Access
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis
Jens Blobner, Laura Dengler, Constantin Eberle, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 12
Open Access
Are we ready for personalized CAR‐T therapy?
Anna Strzelec, Grzegorz Helbig
European Journal Of Haematology (2023) Vol. 112, Iss. 2, pp. 174-183
Open Access | Times Cited: 1
Page 1

Scroll to top